CSBR vs RTX · P/E 16, rev $56.9M vs P/E 36, rev $88.60B
Champions Oncology Inc (CSBR) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the CSBR and RTX stock pages for the full models.
Not investment advice.